A recent Medgadget article reported on a new device aimed at combating the opioid crisis. The RESPMETER wearable biosensor from Altair Medical just achieved a breakthrough device designation from the FDA. The device is a wireless sensor that is worn on a patient’s chest to detect Opioid Induced Respiratory Depression (OIRD), a common deadly side effect associated with the use of opioid drugs. When the RESPMETER detects signs of OIRD, it notifies designated first responders who can intervene by administering naloxone.
Quick Hits: FDA Gives Opioid Overdose Detector Breakthrough Status
The device contains a biosensor that detects fatal side effects of opioid abuse.
Mar 13, 2020